Brazil - Anvisa Resolution RDC 341/2020 Updating the Minimum Quality and Identity Requirements for Single-use Sterile Hypodermic Syringes

​The Anvisa (Brazilian Health Agency) issued the Resolution RDC 341/2020 updating the minimum quality and identity requirements for single-use sterile hypodermic syringes by changing specific articles from the Resolution RDC 003/2011.

The Resolution RDC 341/2020 entries into force after April 1st 2020 and the single-use sterile hypodermic syringes will have a transition period for adaptation:

1) New products: 3 (three) years after April 1st 2020

2) Certified and registered products: 5 (five) years after April 1st 2020.